![Ross Pettit](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ross Pettit
Geschäftsführer bei Charm Therapeutics Ltd.
Aktive Positionen von Ross Pettit
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Charm Therapeutics Ltd.
![]() Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Geschäftsführer | 04.01.2023 | - |
Karriereverlauf von Ross Pettit
Ehemalige bekannte Positionen von Ross Pettit
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Coley Pharmaceutical Group, Inc.
![]() Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | - |
PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01.01.1992 | 01.01.1992 |
AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
BEIGENE, LTD. | Corporate Officer/Principal | 03.10.2016 | - |
ARIAD PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2007 | - |
Ausbildung von Ross Pettit
University of Phoenix | Masters Business Admin |
Kingston University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Vereinigtes Königreich | 3 |
Cayman Islands | 2 |
Operativ
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BEIGENE, LTD. | Health Technology |
INFINITY PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
ARIAD Pharmaceuticals, Inc.
![]() ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Coley Pharmaceutical Group, Inc.
![]() Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
PAREXEL International Corp.
![]() PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
AMAG Pharmaceuticals, Inc.
![]() AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Charm Therapeutics Ltd.
![]() Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Health Technology |
- Börse
- Insiders
- Ross Pettit
- Erfahrung